Safety of continuous subcutaneous insulin infusion: Metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1982-03

AUTHORS

J. C. Pickup, G. C. Viberti, R. W. Bilous, H. Keen, K. G. M. M. Alberti, P. D. Home, C. Binder

ABSTRACT

To assess the rate of metabolic deterioration and potential risks of failure of continuous subcutaneous insulin infusion during basal insulin delivery, we deliberately stopped infusion in nine insulin dependent diabetics. Plasma glucose, blood 3-hydroxybutyrate and plasma free insulin were measured for 9 h whilst the patients remained supine and fasting. Mean plasma glucose remained unchanged at normal fasting levels for the first hour, then rose to plateau at about 10 mmol/l until the end of the experiment. The final plateau level of glucose varied from patient to patient; two C-peptide secreting diabetics plateaued at low glucose levels. In contrast, blood 3-hydroxybutyrate rose progressively, without plateauing. Plasma free insulin concentrations fell during the withdrawal period and there was a highly significant negative correlation between free insulin and 3-hydroxybutyrate. No patient was more than mildly unwell after 9 h of insulin deprivation. We conclude that under these experimental conditions there is glycaemic autoregulation and that ketones may sometimes be a more appropriate monitor of insulin deficiency or loss of diabetic control than is glucose. Accidental failure of continuous subcutaneous insulin infusion and interruption of basal delivery in resting and fasting diabetics will probably not cause dangerous metabolic or clinical deterioration. More... »

PAGES

175-179

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00283748

DOI

http://dx.doi.org/10.1007/bf00283748

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045014773

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7042428


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "3-Hydroxybutyric Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Peptide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fasting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxybutyrates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin Infusion Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Unit for Metabolic Medicine, Guy's Hospital Medical School, London", 
          "id": "http://www.grid.ac/institutes/grid.239826.4", 
          "name": [
            "Unit for Metabolic Medicine, Guy's Hospital Medical School, London"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pickup", 
        "givenName": "J. C.", 
        "id": "sg:person.01276470361.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276470361.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit for Metabolic Medicine, Guy's Hospital Medical School, London", 
          "id": "http://www.grid.ac/institutes/grid.239826.4", 
          "name": [
            "Unit for Metabolic Medicine, Guy's Hospital Medical School, London"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Viberti", 
        "givenName": "G. C.", 
        "id": "sg:person.012321673777.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012321673777.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit for Metabolic Medicine, Guy's Hospital Medical School, London", 
          "id": "http://www.grid.ac/institutes/grid.239826.4", 
          "name": [
            "Unit for Metabolic Medicine, Guy's Hospital Medical School, London"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bilous", 
        "givenName": "R. W.", 
        "id": "sg:person.014554712504.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014554712504.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit for Metabolic Medicine, Guy's Hospital Medical School, London", 
          "id": "http://www.grid.ac/institutes/grid.239826.4", 
          "name": [
            "Unit for Metabolic Medicine, Guy's Hospital Medical School, London"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Keen", 
        "givenName": "H.", 
        "id": "sg:person.01042343611.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK", 
          "id": "http://www.grid.ac/institutes/grid.419334.8", 
          "name": [
            "Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alberti", 
        "givenName": "K. G. M. M.", 
        "id": "sg:person.01117022431.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117022431.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK", 
          "id": "http://www.grid.ac/institutes/grid.419334.8", 
          "name": [
            "Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Home", 
        "givenName": "P. D.", 
        "id": "sg:person.01002541711.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002541711.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Memorial Hospital, Gentofte, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Memorial Hospital, Gentofte, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Binder", 
        "givenName": "C.", 
        "id": "sg:person.01061437054.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061437054.45"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1982-03", 
    "datePublishedReg": "1982-03-01", 
    "description": "To assess the rate of metabolic deterioration and potential risks of failure of continuous subcutaneous insulin infusion during basal insulin delivery, we deliberately stopped infusion in nine insulin dependent diabetics. Plasma glucose, blood 3-hydroxybutyrate and plasma free insulin were measured for 9 h whilst the patients remained supine and fasting. Mean plasma glucose remained unchanged at normal fasting levels for the first hour, then rose to plateau at about 10 mmol/l until the end of the experiment. The final plateau level of glucose varied from patient to patient; two C-peptide secreting diabetics plateaued at low glucose levels. In contrast, blood 3-hydroxybutyrate rose progressively, without plateauing. Plasma free insulin concentrations fell during the withdrawal period and there was a highly significant negative correlation between free insulin and 3-hydroxybutyrate. No patient was more than mildly unwell after 9 h of insulin deprivation. We conclude that under these experimental conditions there is glycaemic autoregulation and that ketones may sometimes be a more appropriate monitor of insulin deficiency or loss of diabetic control than is glucose. Accidental failure of continuous subcutaneous insulin infusion and interruption of basal delivery in resting and fasting diabetics will probably not cause dangerous metabolic or clinical deterioration.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00283748", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "continuous subcutaneous insulin infusion", 
      "subcutaneous insulin infusion", 
      "insulin infusion", 
      "metabolic deterioration", 
      "plasma glucose", 
      "free insulin", 
      "insulin-dependent diabetics", 
      "free insulin concentrations", 
      "mean plasma glucose", 
      "normal fasting levels", 
      "low glucose levels", 
      "basal insulin delivery", 
      "clinical deterioration", 
      "dependent diabetics", 
      "diabetic control", 
      "fasting levels", 
      "insulin deficiency", 
      "C-peptide", 
      "insulin concentrations", 
      "glucose levels", 
      "infusion", 
      "significant negative correlation", 
      "withdrawal period", 
      "insulin deprivation", 
      "diabetics", 
      "insulin delivery", 
      "basal delivery", 
      "plateau level", 
      "patients", 
      "first hour", 
      "insulin", 
      "blood", 
      "final plateau level", 
      "glucose", 
      "appropriate monitors", 
      "autoregulation", 
      "potential risk", 
      "negative correlation", 
      "delivery", 
      "deterioration", 
      "failure", 
      "supine", 
      "levels", 
      "cessation", 
      "risk", 
      "deprivation", 
      "deficiency", 
      "hours", 
      "safety", 
      "interruption", 
      "period", 
      "control", 
      "rate", 
      "contrast", 
      "correlation", 
      "loss", 
      "concentration", 
      "monitor", 
      "experimental conditions", 
      "end", 
      "conditions", 
      "plateau", 
      "experiments", 
      "ketones", 
      "accidental failures"
    ], 
    "name": "Safety of continuous subcutaneous insulin infusion: Metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion", 
    "pagination": "175-179", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045014773"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00283748"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7042428"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00283748", 
      "https://app.dimensions.ai/details/publication/pub.1045014773"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_175.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00283748"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00283748'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00283748'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00283748'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00283748'


 

This table displays all metadata directly associated to this object as RDF triples.

222 TRIPLES      20 PREDICATES      103 URIs      95 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00283748 schema:about N0777e22e16db4f1b8e1324da6bb0fba3
2 N2217943afd1d4636b0331fb2f605dac8
3 N2cba5d94606e4a3ca1d0702491e973c5
4 N3596ebb7471541f7837fe35808611850
5 N3a312eb56ce548078a45a9ac682b653f
6 N50fd362a094349fa9f25cb9164b0d6c9
7 N5a998436782b47879414f55631091a08
8 N7065ae3019624921adf265223d7ab44e
9 Naea554f00af84fe6b8d14c6024f2ddef
10 Nc297899a75dc4875b6e962023ad78f5f
11 Nc7a1ee57bf6243f98c6f6b8ce67477ce
12 Nea519d19482645b8924aeab44cac2c16
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author N9c26a6ecdb584f5a95960cb89b9cc3ba
16 schema:datePublished 1982-03
17 schema:datePublishedReg 1982-03-01
18 schema:description To assess the rate of metabolic deterioration and potential risks of failure of continuous subcutaneous insulin infusion during basal insulin delivery, we deliberately stopped infusion in nine insulin dependent diabetics. Plasma glucose, blood 3-hydroxybutyrate and plasma free insulin were measured for 9 h whilst the patients remained supine and fasting. Mean plasma glucose remained unchanged at normal fasting levels for the first hour, then rose to plateau at about 10 mmol/l until the end of the experiment. The final plateau level of glucose varied from patient to patient; two C-peptide secreting diabetics plateaued at low glucose levels. In contrast, blood 3-hydroxybutyrate rose progressively, without plateauing. Plasma free insulin concentrations fell during the withdrawal period and there was a highly significant negative correlation between free insulin and 3-hydroxybutyrate. No patient was more than mildly unwell after 9 h of insulin deprivation. We conclude that under these experimental conditions there is glycaemic autoregulation and that ketones may sometimes be a more appropriate monitor of insulin deficiency or loss of diabetic control than is glucose. Accidental failure of continuous subcutaneous insulin infusion and interruption of basal delivery in resting and fasting diabetics will probably not cause dangerous metabolic or clinical deterioration.
19 schema:genre article
20 schema:isAccessibleForFree true
21 schema:isPartOf N5f016c74a6fc47a584f4818d2518f8e3
22 Nc0e6485d341e46c2997ea70d0bbef79c
23 sg:journal.1001482
24 schema:keywords C-peptide
25 accidental failures
26 appropriate monitors
27 autoregulation
28 basal delivery
29 basal insulin delivery
30 blood
31 cessation
32 clinical deterioration
33 concentration
34 conditions
35 continuous subcutaneous insulin infusion
36 contrast
37 control
38 correlation
39 deficiency
40 delivery
41 dependent diabetics
42 deprivation
43 deterioration
44 diabetic control
45 diabetics
46 end
47 experimental conditions
48 experiments
49 failure
50 fasting levels
51 final plateau level
52 first hour
53 free insulin
54 free insulin concentrations
55 glucose
56 glucose levels
57 hours
58 infusion
59 insulin
60 insulin concentrations
61 insulin deficiency
62 insulin delivery
63 insulin deprivation
64 insulin infusion
65 insulin-dependent diabetics
66 interruption
67 ketones
68 levels
69 loss
70 low glucose levels
71 mean plasma glucose
72 metabolic deterioration
73 monitor
74 negative correlation
75 normal fasting levels
76 patients
77 period
78 plasma glucose
79 plateau
80 plateau level
81 potential risk
82 rate
83 risk
84 safety
85 significant negative correlation
86 subcutaneous insulin infusion
87 supine
88 withdrawal period
89 schema:name Safety of continuous subcutaneous insulin infusion: Metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion
90 schema:pagination 175-179
91 schema:productId N3312713943414ffc87e78b56b19d3ab5
92 Nb713a2b14f4b4d4c90d3a89423806ed0
93 Neacd372bc30745038ef64041eb5f90d9
94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045014773
95 https://doi.org/10.1007/bf00283748
96 schema:sdDatePublished 2022-12-01T06:18
97 schema:sdLicense https://scigraph.springernature.com/explorer/license/
98 schema:sdPublisher Nf741b1f577e2436c9d2d2354220208c9
99 schema:url https://doi.org/10.1007/bf00283748
100 sgo:license sg:explorer/license/
101 sgo:sdDataset articles
102 rdf:type schema:ScholarlyArticle
103 N0777e22e16db4f1b8e1324da6bb0fba3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Kinetics
105 rdf:type schema:DefinedTerm
106 N0b937858e61c43ddaf18d9733fa75f5b rdf:first sg:person.01042343611.09
107 rdf:rest Ne5fd4c16a9a846d28446a058daec813c
108 N1a2ee695d23f4b62b5e424eb5231cf9f rdf:first sg:person.014554712504.12
109 rdf:rest N0b937858e61c43ddaf18d9733fa75f5b
110 N2217943afd1d4636b0331fb2f605dac8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Insulin
112 rdf:type schema:DefinedTerm
113 N2cba5d94606e4a3ca1d0702491e973c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Hydroxybutyrates
115 rdf:type schema:DefinedTerm
116 N3312713943414ffc87e78b56b19d3ab5 schema:name dimensions_id
117 schema:value pub.1045014773
118 rdf:type schema:PropertyValue
119 N3596ebb7471541f7837fe35808611850 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Adult
121 rdf:type schema:DefinedTerm
122 N3a312eb56ce548078a45a9ac682b653f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name 3-Hydroxybutyric Acid
124 rdf:type schema:DefinedTerm
125 N50fd362a094349fa9f25cb9164b0d6c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Middle Aged
127 rdf:type schema:DefinedTerm
128 N5a998436782b47879414f55631091a08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Diabetes Mellitus
130 rdf:type schema:DefinedTerm
131 N5f016c74a6fc47a584f4818d2518f8e3 schema:volumeNumber 22
132 rdf:type schema:PublicationVolume
133 N7065ae3019624921adf265223d7ab44e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Insulin Infusion Systems
135 rdf:type schema:DefinedTerm
136 N9c26a6ecdb584f5a95960cb89b9cc3ba rdf:first sg:person.01276470361.10
137 rdf:rest Nc37bc158d7cd48fa94f273528cd7fccd
138 Naea554f00af84fe6b8d14c6024f2ddef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Humans
140 rdf:type schema:DefinedTerm
141 Nb713a2b14f4b4d4c90d3a89423806ed0 schema:name doi
142 schema:value 10.1007/bf00283748
143 rdf:type schema:PropertyValue
144 Nb8e6ade63a404898ac036f6699301ed0 rdf:first sg:person.01002541711.37
145 rdf:rest Ncd2f937cbdd4422b856be605faeeacc6
146 Nc0e6485d341e46c2997ea70d0bbef79c schema:issueNumber 3
147 rdf:type schema:PublicationIssue
148 Nc297899a75dc4875b6e962023ad78f5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Blood Glucose
150 rdf:type schema:DefinedTerm
151 Nc37bc158d7cd48fa94f273528cd7fccd rdf:first sg:person.012321673777.25
152 rdf:rest N1a2ee695d23f4b62b5e424eb5231cf9f
153 Nc7a1ee57bf6243f98c6f6b8ce67477ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name C-Peptide
155 rdf:type schema:DefinedTerm
156 Ncd2f937cbdd4422b856be605faeeacc6 rdf:first sg:person.01061437054.45
157 rdf:rest rdf:nil
158 Ne5fd4c16a9a846d28446a058daec813c rdf:first sg:person.01117022431.61
159 rdf:rest Nb8e6ade63a404898ac036f6699301ed0
160 Nea519d19482645b8924aeab44cac2c16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Fasting
162 rdf:type schema:DefinedTerm
163 Neacd372bc30745038ef64041eb5f90d9 schema:name pubmed_id
164 schema:value 7042428
165 rdf:type schema:PropertyValue
166 Nf741b1f577e2436c9d2d2354220208c9 schema:name Springer Nature - SN SciGraph project
167 rdf:type schema:Organization
168 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical and Health Sciences
170 rdf:type schema:DefinedTerm
171 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
172 schema:name Clinical Sciences
173 rdf:type schema:DefinedTerm
174 sg:journal.1001482 schema:issn 0012-186X
175 1432-0428
176 schema:name Diabetologia
177 schema:publisher Springer Nature
178 rdf:type schema:Periodical
179 sg:person.01002541711.37 schema:affiliation grid-institutes:grid.419334.8
180 schema:familyName Home
181 schema:givenName P. D.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002541711.37
183 rdf:type schema:Person
184 sg:person.01042343611.09 schema:affiliation grid-institutes:grid.239826.4
185 schema:familyName Keen
186 schema:givenName H.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09
188 rdf:type schema:Person
189 sg:person.01061437054.45 schema:affiliation grid-institutes:grid.419658.7
190 schema:familyName Binder
191 schema:givenName C.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061437054.45
193 rdf:type schema:Person
194 sg:person.01117022431.61 schema:affiliation grid-institutes:grid.419334.8
195 schema:familyName Alberti
196 schema:givenName K. G. M. M.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117022431.61
198 rdf:type schema:Person
199 sg:person.012321673777.25 schema:affiliation grid-institutes:grid.239826.4
200 schema:familyName Viberti
201 schema:givenName G. C.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012321673777.25
203 rdf:type schema:Person
204 sg:person.01276470361.10 schema:affiliation grid-institutes:grid.239826.4
205 schema:familyName Pickup
206 schema:givenName J. C.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276470361.10
208 rdf:type schema:Person
209 sg:person.014554712504.12 schema:affiliation grid-institutes:grid.239826.4
210 schema:familyName Bilous
211 schema:givenName R. W.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014554712504.12
213 rdf:type schema:Person
214 grid-institutes:grid.239826.4 schema:alternateName Unit for Metabolic Medicine, Guy's Hospital Medical School, London
215 schema:name Unit for Metabolic Medicine, Guy's Hospital Medical School, London
216 rdf:type schema:Organization
217 grid-institutes:grid.419334.8 schema:alternateName Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
218 schema:name Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
219 rdf:type schema:Organization
220 grid-institutes:grid.419658.7 schema:alternateName Steno Memorial Hospital, Gentofte, Copenhagen, Denmark
221 schema:name Steno Memorial Hospital, Gentofte, Copenhagen, Denmark
222 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...